社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
小牛市
IP属地：未知
+关注
帖子 · 48
帖子 · 48
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
小牛市
小牛市
·
2022-01-19
$Grab Holdings(GRAB)$
good to buy?
看
2,558
回复
3
点赞
2
编组 21备份 2
分享
举报
小牛市
小牛市
·
2021-12-26
$Peloton Interactive, Inc.(PTON)$
will u turn green next week?
看
1,829
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
小牛市
小牛市
·
2021-12-26
$Futu Holdings Limited(FUTU)$
will u to the moon next week? 😜
看
1,540
回复
评论
点赞
2
编组 21备份 2
分享
举报
小牛市
小牛市
·
2021-12-21
👍
非常抱歉，此主贴已删除
看
1,869
回复
1
点赞
3
编组 21备份 2
分享
举报
小牛市
小牛市
·
2021-12-08
$Nano Dimension(NNDM)$
It time to buy more? 😜
看
1,790
回复
评论
点赞
6
编组 21备份 2
分享
举报
小牛市
小牛市
·
2021-11-30
Nice
NRx Pharmaceuticals stock surged 27% in morning trading
NRx Pharmaceuticals stock surged 27% in morning trading after it identified significantly higher lik
NRx Pharmaceuticals stock surged 27% in morning trading
看
1,757
回复
1
点赞
5
编组 21备份 2
分享
举报
小牛市
小牛市
·
2021-11-25
$OLAM INTERNATIONAL LIMITED(O32.SI)$
Nice😎
看
1,783
回复
评论
点赞
5
编组 21备份 2
分享
举报
小牛市
小牛市
·
2021-11-20
$Camber Energy(CEI)$
what happen on Post market? 😜
看
2,364
回复
1
点赞
2
编组 21备份 2
分享
举报
小牛市
小牛市
·
2021-11-08
$Bank of America(BAC)$
up
看
1,621
回复
评论
点赞
2
编组 21备份 2
分享
举报
小牛市
小牛市
·
2021-11-04
$Futu Holdings Limited(FUTU)$
can buy more? 😜
看
1,647
回复
评论
点赞
2
编组 21备份 2
分享
举报
加载更多
暂无关注
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3574851011010933","uuid":"3574851011010933","gmtCreate":1611757523250,"gmtModify":1625149890018,"name":"小牛市","pinyin":"xnsxiaoniushi","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/36ec2a25f7386d85a759d0e5256da3f1","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":5,"headSize":128,"tweetSize":48,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.10.25","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.30","exceedPercentage":"60.67%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.05.10","exceedPercentage":"80.20%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":697782209,"gmtCreate":1642594331727,"gmtModify":1642594332176,"author":{"id":"3574851011010933","authorId":"3574851011010933","name":"小牛市","avatar":"https://static.tigerbbs.com/36ec2a25f7386d85a759d0e5256da3f1","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574851011010933","authorIdStr":"3574851011010933"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GRAB\">$Grab Holdings(GRAB)$</a> good to buy? ","listText":"<a href=\"https://laohu8.com/S/GRAB\">$Grab Holdings(GRAB)$</a> good to buy? ","text":"$Grab Holdings(GRAB)$ good to buy?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/697782209","isVote":1,"tweetType":1,"viewCount":2558,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698496621,"gmtCreate":1640485735841,"gmtModify":1640485736005,"author":{"id":"3574851011010933","authorId":"3574851011010933","name":"小牛市","avatar":"https://static.tigerbbs.com/36ec2a25f7386d85a759d0e5256da3f1","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574851011010933","authorIdStr":"3574851011010933"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PTON\">$Peloton Interactive, Inc.(PTON)$</a>will u turn green next week? ","listText":"<a href=\"https://laohu8.com/S/PTON\">$Peloton Interactive, Inc.(PTON)$</a>will u turn green next week? ","text":"$Peloton Interactive, Inc.(PTON)$will u turn green next week?","images":[{"img":"https://static.tigerbbs.com/7761745a7aaf43b0861534bd6688b15b","width":"1080","height":"2340"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698496621","isVote":1,"tweetType":1,"viewCount":1829,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":698499690,"gmtCreate":1640485156653,"gmtModify":1640485206981,"author":{"id":"3574851011010933","authorId":"3574851011010933","name":"小牛市","avatar":"https://static.tigerbbs.com/36ec2a25f7386d85a759d0e5256da3f1","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574851011010933","authorIdStr":"3574851011010933"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FUTU\">$Futu Holdings Limited(FUTU)$</a> will u to the moon next week? 😜 ","listText":"<a href=\"https://laohu8.com/S/FUTU\">$Futu Holdings Limited(FUTU)$</a> will u to the moon next week? 😜 ","text":"$Futu Holdings Limited(FUTU)$ will u to the moon next week? 😜","images":[{"img":"https://static.tigerbbs.com/90b4ab312be332d901bd765e9c2fb3a9","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698499690","isVote":1,"tweetType":1,"viewCount":1540,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":693282470,"gmtCreate":1640040917379,"gmtModify":1640040965740,"author":{"id":"3574851011010933","authorId":"3574851011010933","name":"小牛市","avatar":"https://static.tigerbbs.com/36ec2a25f7386d85a759d0e5256da3f1","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574851011010933","authorIdStr":"3574851011010933"},"themes":[],"htmlText":" 👍 ","listText":" 👍 ","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693282470","repostId":"1140794695","repostType":4,"isVote":1,"tweetType":1,"viewCount":1869,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602307720,"gmtCreate":1638968177955,"gmtModify":1638968178082,"author":{"id":"3574851011010933","authorId":"3574851011010933","name":"小牛市","avatar":"https://static.tigerbbs.com/36ec2a25f7386d85a759d0e5256da3f1","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574851011010933","authorIdStr":"3574851011010933"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NNDM\">$Nano Dimension(NNDM)$</a> It time to buy more? 😜 ","listText":"<a href=\"https://laohu8.com/S/NNDM\">$Nano Dimension(NNDM)$</a> It time to buy more? 😜 ","text":"$Nano Dimension(NNDM)$ It time to buy more? 😜","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602307720","isVote":1,"tweetType":1,"viewCount":1790,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609023205,"gmtCreate":1638225388337,"gmtModify":1638225388517,"author":{"id":"3574851011010933","authorId":"3574851011010933","name":"小牛市","avatar":"https://static.tigerbbs.com/36ec2a25f7386d85a759d0e5256da3f1","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574851011010933","authorIdStr":"3574851011010933"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609023205","repostId":"1137204965","repostType":4,"repost":{"id":"1137204965","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638199520,"share":"https://ttm.financial/m/news/1137204965?lang=&edition=full","pubTime":"2021-11-29 23:25","market":"us","language":"en","title":"NRx Pharmaceuticals stock surged 27% in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1137204965","media":"Tiger Newspress","summary":"NRx Pharmaceuticals stock surged 27% in morning trading after it identified significantly higher lik","content":"<p>NRx Pharmaceuticals stock surged 27% in morning trading after it identified significantly higher likelihood of surviving and recovering from Critical COVID-19 in ZYESAMI® (aviptadil) treated patients previously administered remdesivir.</p>\n<p><img src=\"https://static.tigerbbs.com/50a474a64f50c3ff0cfc1f4f77930314\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n<p>NRx Pharmaceuticals announced today that it has completed an analysis to identify clinical evidence that indicates a substantial improvement after treatment with ZYESAMI® (aviptadil) in patients with Critical COVID-19 and Respiratory Failure over existing therapies such as remdesivir. NRx asked Prof. David Schoenfeld, one of the world’s most widely published statisticians with unique expertise in life-threatening diseases of the lung to conduct the analysis.</p>\n<ul>\n <li><p>Analysis was conducted in the subgroup of ZYESAMI- and placebo-treated patients who were previously treated with remdesivir in the COVID-AIV trial representing approximately 70 percent of the study population</p></li>\n <li><p>Analysis was conducted in response to US Food and Drug Administration (FDA) request for additional clinical data on effect of ZYESAMI compared to currently-approved therapy including remdesivir</p></li>\n <li><p>NRx to submit new analysis and safety data to the FDA in support of Emergency Use Authorization and Breakthrough Therapy Designation Requests</p></li>\n <li><p>US National Institutes of Health-sponsored trial to compare effects of ZYESAMI and remdesivir individually and in combination continues to enroll patients</p></li>\n</ul>\n<ul></ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>NRx Pharmaceuticals stock surged 27% in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNRx Pharmaceuticals stock surged 27% in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-29 23:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NRx Pharmaceuticals stock surged 27% in morning trading after it identified significantly higher likelihood of surviving and recovering from Critical COVID-19 in ZYESAMI® (aviptadil) treated patients previously administered remdesivir.</p>\n<p><img src=\"https://static.tigerbbs.com/50a474a64f50c3ff0cfc1f4f77930314\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n<p>NRx Pharmaceuticals announced today that it has completed an analysis to identify clinical evidence that indicates a substantial improvement after treatment with ZYESAMI® (aviptadil) in patients with Critical COVID-19 and Respiratory Failure over existing therapies such as remdesivir. NRx asked Prof. David Schoenfeld, one of the world’s most widely published statisticians with unique expertise in life-threatening diseases of the lung to conduct the analysis.</p>\n<ul>\n <li><p>Analysis was conducted in the subgroup of ZYESAMI- and placebo-treated patients who were previously treated with remdesivir in the COVID-AIV trial representing approximately 70 percent of the study population</p></li>\n <li><p>Analysis was conducted in response to US Food and Drug Administration (FDA) request for additional clinical data on effect of ZYESAMI compared to currently-approved therapy including remdesivir</p></li>\n <li><p>NRx to submit new analysis and safety data to the FDA in support of Emergency Use Authorization and Breakthrough Therapy Designation Requests</p></li>\n <li><p>US National Institutes of Health-sponsored trial to compare effects of ZYESAMI and remdesivir individually and in combination continues to enroll patients</p></li>\n</ul>\n<ul></ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NRXP":"NRX Pharmaceuticals Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137204965","content_text":"NRx Pharmaceuticals stock surged 27% in morning trading after it identified significantly higher likelihood of surviving and recovering from Critical COVID-19 in ZYESAMI® (aviptadil) treated patients previously administered remdesivir.\n\nNRx Pharmaceuticals announced today that it has completed an analysis to identify clinical evidence that indicates a substantial improvement after treatment with ZYESAMI® (aviptadil) in patients with Critical COVID-19 and Respiratory Failure over existing therapies such as remdesivir. NRx asked Prof. David Schoenfeld, one of the world’s most widely published statisticians with unique expertise in life-threatening diseases of the lung to conduct the analysis.\n\nAnalysis was conducted in the subgroup of ZYESAMI- and placebo-treated patients who were previously treated with remdesivir in the COVID-AIV trial representing approximately 70 percent of the study population\nAnalysis was conducted in response to US Food and Drug Administration (FDA) request for additional clinical data on effect of ZYESAMI compared to currently-approved therapy including remdesivir\nNRx to submit new analysis and safety data to the FDA in support of Emergency Use Authorization and Breakthrough Therapy Designation Requests\nUS National Institutes of Health-sponsored trial to compare effects of ZYESAMI and remdesivir individually and in combination continues to enroll patients","news_type":1,"symbols_score_info":{"NRXP":0.9}},"isVote":1,"tweetType":1,"viewCount":1757,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874771554,"gmtCreate":1637831891190,"gmtModify":1637831891190,"author":{"id":"3574851011010933","authorId":"3574851011010933","name":"小牛市","avatar":"https://static.tigerbbs.com/36ec2a25f7386d85a759d0e5256da3f1","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574851011010933","authorIdStr":"3574851011010933"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/O32.SI\">$OLAM INTERNATIONAL LIMITED(O32.SI)$</a>Nice😎","listText":"<a href=\"https://laohu8.com/S/O32.SI\">$OLAM INTERNATIONAL LIMITED(O32.SI)$</a>Nice😎","text":"$OLAM INTERNATIONAL LIMITED(O32.SI)$Nice😎","images":[{"img":"https://static.tigerbbs.com/3e0518aff0df067e9bb18510cf375011","width":"1080","height":"3331"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874771554","isVote":1,"tweetType":1,"viewCount":1783,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":876785888,"gmtCreate":1637365386493,"gmtModify":1637365386664,"author":{"id":"3574851011010933","authorId":"3574851011010933","name":"小牛市","avatar":"https://static.tigerbbs.com/36ec2a25f7386d85a759d0e5256da3f1","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574851011010933","authorIdStr":"3574851011010933"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CEI\">$Camber Energy(CEI)$</a> what happen on Post market? 😜 ","listText":"<a href=\"https://laohu8.com/S/CEI\">$Camber Energy(CEI)$</a> what happen on Post market? 😜 ","text":"$Camber Energy(CEI)$ what happen on Post market? 😜","images":[{"img":"https://static.tigerbbs.com/27e02bc491e755dd1140edcb983feae8","width":"1080","height":"3415"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/876785888","isVote":1,"tweetType":1,"viewCount":2364,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":845889937,"gmtCreate":1636328360324,"gmtModify":1636328360456,"author":{"id":"3574851011010933","authorId":"3574851011010933","name":"小牛市","avatar":"https://static.tigerbbs.com/36ec2a25f7386d85a759d0e5256da3f1","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574851011010933","authorIdStr":"3574851011010933"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BAC\">$Bank of America(BAC)$</a>up","listText":"<a href=\"https://laohu8.com/S/BAC\">$Bank of America(BAC)$</a>up","text":"$Bank of America(BAC)$up","images":[{"img":"https://static.tigerbbs.com/41a1f2603ab27f3eb1b92535d133a746","width":"1080","height":"3415"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/845889937","isVote":1,"tweetType":1,"viewCount":1621,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":848895404,"gmtCreate":1635987704438,"gmtModify":1635987704603,"author":{"id":"3574851011010933","authorId":"3574851011010933","name":"小牛市","avatar":"https://static.tigerbbs.com/36ec2a25f7386d85a759d0e5256da3f1","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574851011010933","authorIdStr":"3574851011010933"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FUTU\">$Futu Holdings Limited(FUTU)$</a> can buy more? 😜 ","listText":"<a href=\"https://laohu8.com/S/FUTU\">$Futu Holdings Limited(FUTU)$</a> can buy more? 😜 ","text":"$Futu Holdings Limited(FUTU)$ can buy more? 😜","images":[{"img":"https://static.tigerbbs.com/cbdd8d074d552fa41283840e0f12f11a","width":"1080","height":"3526"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/848895404","isVote":1,"tweetType":1,"viewCount":1647,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0}],"defaultTab":"following","isTTM":false}
